NCT06328283View on ClinicalTrials.gov

The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

measure of Glutamine synthetase and BCLFAF1

compare Glutamine synthetase and BCLFAF1 in cases and controls

Trial Locations (1)

Unknown

Sohag university Hospital, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT06328283 - The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients | Biotech Hunter | Biotech Hunter